Co-Authors
This is a "connection" page, showing publications co-authored by Axel Nierhaus and Gernot Marx.
Connection Strength
0.259
-
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial. Trials. 2019 Mar 04; 20(1):156.
Score: 0.203
-
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules. 2020 08 11; 10(8).
Score: 0.056